Candida auris : L’émergence d’un champignon résistant et mortel

Paris – 29 Février 2024 –

L’Organisation Mondiale de la Santé (OMS) alerte sur la propagation rapide de Candida auris, un champignon particulièrement dangereux et résistant aux traitements antifongiques. Identifié pour la première fois en 2009 au Japon,ce champignon est désormais présent sur six continents et se propage facilement dans les milieux hospitaliers,affectant principalement les personnes immunodéprimées.Cette menace croissante pour la santé publique exige une vigilance accrue et des mesures de contrôle strictes.Découvrez les détails de cette infection émergente et les risques associés.

Here’s a summary of the article, focusing on the key details:

The article discusses Candida auris (C.auris), a dangerous and increasingly resistant fungus identified by the World Health Organization (WHO) as a serious threat to humanity.

Key points:

Deadly: C. auris can cause devastating infections, especially in peopel with weakened immune systems.
Widespread: First discovered in 2009 in Japan, it’s now found in over 40 countries across six continents.
Hospital-borne: It thrives in hospital environments, surviving on surfaces and even on human skin without causing symptoms, making it easily spreadable. Drug Resistance: Overuse of antifungals (in healthcare and agriculture) has led to the fungus developing resistance to many treatments. Easy access to antifungals in some countries without prescription exacerbates the problem.
High-Risk Groups: Those with compromised immune systems, recent ICU patients, and those treated with certain antibiotics are most vulnerable.
Monitoring: In the UK, all cases of C. auris must be reported to health authorities.
WHO Priority: The WHO lists C. auris among the most dangerous fungal pathogens, alongside Aspergillus fumigatus, Candida albicans, and Cryptococcus neoformans*.In essence, the article warns about a growing public health threat due to a resilient and easily spreadable fungus, notably in healthcare settings.